These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19641036)

  • 1. Regulation of dendritic cell survival and cytokine production by osteoprotegerin.
    Chino T; Draves KE; Clark EA
    J Leukoc Biol; 2009 Oct; 86(4):933-40. PubMed ID: 19641036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.
    Shimamura M; Nakagami H; Osako MK; Kurinami H; Koriyama H; Zhengda P; Tomioka H; Tenma A; Wakayama K; Morishita R
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8191-6. PubMed ID: 24847069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin mediate RANK/RANKL signaling inhibition eases asthma inflammatory reaction by affecting the survival and function of dendritic cells.
    Yang X; Wang X; Chi M; Zhang M; Shan H; Zhang QH; Zhang J; Shi J; Zhang JZ; Wu RM; Li YL
    Allergol Immunopathol (Madr); 2019; 47(2):179-184. PubMed ID: 30292447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved.
    Sutton KM; Hu T; Wu Z; Siklodi B; Vervelde L; Kaiser P
    Dev Comp Immunol; 2015 Jul; 51(1):170-84. PubMed ID: 25796577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N; Maeda H; Yoshimine Y; Akamine A
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines.
    Duka M; Eraković M; Dolićanin Z; Stefanović D; Čolić M
    Mediators Inflamm; 2019; 2019():8325380. PubMed ID: 31011287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
    Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A
    BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent.
    Schoppet M; Henser S; Ruppert V; Stübig T; Al-Fakhri N; Maisch B; Hofbauer LC
    J Cell Biochem; 2007 Apr; 100(6):1430-9. PubMed ID: 17171649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice.
    Maruyama K; Takada Y; Ray N; Kishimoto Y; Penninger JM; Yasuda H; Matsuo K
    J Immunol; 2006 Sep; 177(6):3799-805. PubMed ID: 16951341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANK/RANKL/OPG system in the intervertebral disc.
    Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A
    Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
    Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of technetium-99 conjugated with methylene diphosphonate (
    Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
    J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.
    Fiumara P; Snell V; Li Y; Mukhopadhyay A; Younes M; Gillenwater AM; Cabanillas F; Aggarwal BB; Younes A
    Blood; 2001 Nov; 98(9):2784-90. PubMed ID: 11675352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways.
    Vitovski S; Phillips JS; Sayers J; Croucher PI
    J Biol Chem; 2007 Oct; 282(43):31601-9. PubMed ID: 17702740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells.
    Wang Z; Ding L; Zhang S; Jiang T; Yang Y; Li R
    Int J Mol Med; 2014 Dec; 34(6):1720-6. PubMed ID: 25270538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
    Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
    J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redundant modulatory effects of proinflammatory cytokines in human osteoblastic cells in vitro.
    Di Benedetto G; Lempereur L; Valle D; Greco EA; Bernardini R; Lenzi A; Migliaccio S
    Clin Exp Rheumatol; 2018; 36(6):959-969. PubMed ID: 29998830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG.
    Aoyama E; Kubota S; Khattab HM; Nishida T; Takigawa M
    Bone; 2015 Apr; 73():242-8. PubMed ID: 25554597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.